Company Number: 12807636

Analysis Date: 2025-07-19 12:44 UTC

Financial Health Assessment of Bee and Fox Limited as at 31 August 2024

---

1. Financial Health Score: C

Explanation:
Bee and Fox Limited demonstrates a modest financial position typical of a micro-entity in its early years. The company's net assets have significantly eroded over the past four years, indicating financial strain. Although it maintains positive net current assets (working capital), the sharp decline in net assets to only £272 signals fragility and potential liquidity risks. The company is not in immediate distress but shows symptoms of financial weakening requiring attention to avoid further deterioration.

---

2. Key Vital Signs

Metric	2024 Value	Interpretation
Net Assets (Equity)	£272	Very low equity buffer; indicates minimal shareholder funds remaining after liabilities.
Current Assets	£11,421	Adequate short-term assets to cover immediate obligations.
Current Liabilities	£5,637	Debts due within one year; manageable given current assets.
Net Current Assets (Working Capital)	£5,784	Positive working capital indicates ability to meet short-term liabilities — a healthy cash flow sign.
Creditors Due After One Year	£15,580	Significant long-term liabilities, contributing to overall low net assets.
Fixed Assets	£10,068	Long-term investments declining from prior year, possibly indicating asset disposals or depreciation.
Share Capital	£100	Nominal capital base typical for a micro-entity.
Average Employees	2	Very small workforce consistent with micro-company status.

---

3. Diagnosis: What the Financial Data Reveals

Bee and Fox Limited shows symptoms of financial distress primarily reflected in its dwindling net assets, which have fallen from £12,367 in 2020 to just £272 in 2024. This steady erosion suggests accumulated losses or insufficient profitability over the years.

Despite this, the company maintains positive working capital of approximately £5,784, indicating it currently has a "healthy cash flow" to cover short-term obligations. This is an encouraging sign, showing the business can meet immediate debts without liquidity pressure.

The presence of significant long-term creditors (£15,580) compared to very low equity is a warning signal. The company’s capital structure is heavily reliant on creditor financing rather than shareholder funds, raising concerns about solvency if liabilities must be repaid suddenly.

The decline in fixed assets may reflect asset disposals to generate cash or asset depreciation, which should be monitored to ensure it doesn't impair operational capacity.

The small scale of operations (two employees, micro-account status) suggests a lean business model but also limits economies of scale and resilience to financial shocks.

---

4. Recommendations: Specific Actions to Improve Financial Wellness

• Improve Profitability:
  Conduct a thorough review of revenue streams and cost structures to halt the erosion of net assets. Enhancing gross margins and reducing overheads will help rebuild equity.

• Strengthen Capital Base:
  Consider injecting additional equity capital or retaining more earnings to improve net assets and reduce dependency on creditor financing. This will bolster solvency and investor confidence.

• Manage Liabilities Carefully:
  Negotiate with long-term creditors to restructure or extend payment terms, easing cash flow pressures and improving balance sheet stability.

• Monitor Cash Flow Rigorously:
  Maintain strong working capital management to ensure ongoing ability to meet short-term liabilities. Implement tighter debtor collection and inventory controls if applicable.

• Asset Management:
  Review fixed asset utilization to ensure assets are productive and aligned with business needs. Avoid unnecessary disposals that could impair operations.

• Strategic Planning:
  Develop a medium-term financial plan focusing on sustainable growth, cost control, and risk management to prevent future financial distress.

---

Medical Analogy Summary:

Bee and Fox Limited exhibits symptoms of financial fatigue—a significant weakening of its equity "immune system" despite a currently stable "heart rhythm" (working capital). Without intervention to strengthen its financial "vital signs," the company risks developing deeper "financial ailments" such as insolvency or inability to invest in growth.

---